Τιμολογήσεις ιατρικών πράξεων

With great pleasure we announce the HDIR–MOKAD–SDIR 2nd Regional Congress (HMS2RC) and the 8th meeting of the Croatian Association for Cancer Research (HDIR-8).The meetings will be held in Zagreb, Croatia, at the Hotel International (Miramarska 24, Zagreb) on November 4 and 5, 2026.The goal of this regional congress is to promote cancer research in Croatia, Turkey and Serbia, focused on the cooperation between basic research and clinical cancer management. This congress will put an emphasis on regional and international communication and cooperation, with speakers from many European and other countries. The HMS2RC provides opportunity for cancer researchers and clinicians to gather together and to establish a good working collaborations with each other and with other regional EACR national societies.Original contributions by researchers and clinicians with an interest in cancer are more than welcome and encouraged. Your contribution to this meeting will mutually benefit all participants and help to make this event successful.We invite you to join us, and we are looking forward to meet you in Zagreb, Croatia.Sincerely,Dr. Petar Ozretić, HDIR PresidentDr. Engin Ulukaya, MOKAD PresidentDr. Milena Čavić, SDIR President

Welcome to the 7th AEK Autumn School 2026Dear colleagues and cancer scientists,It is our great pleasure to announce the 7th AEK Autumn School to be held in Potsdam from November 4th to 6th, 2026.The Autumn School is organized by the Experimental Cancer Research Section of the German Cancer Society ("Abteilung Experimentelle Krebsforschung", AEK), which represents the majority of experimental cancer researchers in Germany. The main goal of the AEK is to stimulate scientific exchange and to support young cancer researchers.The 7th AEK Autumn School addresses recent exciting developments in treating cancers driven by proteins of the RAS family of small GTPases. The topic of the autumn school is unique in that it integrates basic, translational and clinical cancer research.Targeting RAS: Biology, Treatment Resistance and Opportunities for Combinatorial TherapyThe development of the first KRASG12C- inhibitors by Kevan Shokat in 2013 marked a milestone in rendering RAS proteins druggable. Since then, the field has advanced rapidly, driven largely by intensive efforts within biotech companies and the pharmaceutical industry, toward therapeutic implementation and the design of mutation-specific as well as broad-spectrum pan‑RAS inhibitors. Nevertheless, emerging clinical experience indicates that resistance to these agents frequently arises, with the underlying mechanisms being only partially understood. This has created a dynamic area of research focused on elucidating genetic and non-genetic mechanisms as well as immune evasion processes that contribute to resistance. Ultimately, these insights aim to inform the development of rational combination therapies, applicable both in preclinical models and in early‑phase clinical trials.The autumn school’s format with nationally and internationally renowned speakers and a limited number of participants will allow for in-depth and comprehensive discussions in an inspiring environment. Potsdam lies about 25 km southwest of Berlin’s city center and is not only known for its role as a historic Prussian residence city and modern science hub, but also for its dense ensemble of palaces, parks, and lakes. The conference site, Inselhotel Potsdam, is located directly beside the lake Templin on the Hermannswerder Island, in short distance from the main railway station.We are grateful to the German Cancer Society (Deutsche Krebsgesellschaft) and German Cancer Aid (Deutsche Krebshilfe) for their support, enabling us to organize this Autumn School and allowing us to provide travel bursaries for the three participants.Please note that the number of participants is limited to 25. All abstract submitters are cordially invited to present a poster as well as a short or flash talk.We hope you will enjoy the 7th AEK Autumn School's exciting scientific program in an inspiring environment. We are confident that you will return from the conference with many new insights and ideas, as well as with new friends and scientific contacts that will enrich your further scientific work.Kind regards,the organizersChristine SersReinhold SchäferBjörn Papke

Join us this November for the Cancer Research UK Lung Cancer Centre of Excellence Conference. We’re bringing together an exceptional line-up of leading scientists and clinicians highlighting the most recent advances in lung cancer.Themes include:Lung Cancer OriginsSCLC BiologyLung Cancer ImmunotherapyOptimising RadiotherapyLung Cancer & the Nervous SystemDesigned to foster meaningful discussion, expect thought-provoking talks, vibrant poster sessions and a buzzing atmosphere designed to spark collaboration and new ideas.

This upcoming CRT is a follow‑up meeting to the EACH Cardiovascular Health Summit held on 10–11 December 2025, and is conceived as a decisive moment to translate the ambitions expressed at that landmark event into tangible progress. The Cardiovascular Round Table (CRT) entitled “What are we with the Cardiovascular Health Plan?”, taking place on 4–5 November at the European Heart House in Sophia Antipolis, France, will serve as a high‑level strategic appraisal of where Europe now stands in advancing the Cardiovascular Health Plan. Bringing together ESC leadership and key stakeholders, the meeting will rigorously assess progress achieved since EACH, confront persisting gaps and implementation barriers, and forge alignment across scientific, clinical, policy and industry perspectives. Positioned as a cornerstone of the annual CRT programme. This meeting consolidates insights from the year’s thematic CRT discussions and is intended to sharpen priorities and drive the next phase of coordinated, impactful action to strengthen cardiovascular health across Europe.